Cited in boardrooms, legal proceedings & government briefings since 2017
Medical cannabis sales and registered patients in Romania, 2025 actuals and the 2027 forecast. Forecasts to 2030 are in the Romania data pack.
Medical sales, EUR
| Metric | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| Medical sales | — | — | — | |||
| Patients | — | — | — |
Forecasts to 2030 — sales, patients and the full Romania series — are in the Romania data pack, or scoped to your question in a bespoke brief.
See the data pack Request a briefSource: Prohibition Partners — Global Medical Cannabis Market Review (2026, updated April 2026) & The European Cannabis Report (2025)
From International Cannabis Weekly, our free global briefing.
HempToday · №439 · 27 Feb 2026 · Hemp & CBD
№328 · 8 Dec 2023 · Regulation
Cannabis Health · №275 · 25 Nov 2022 · Events & Industry
seenews.com · №186 · 26 Feb 2021 · Business & Investment
№103-3 · 5 Jul 2019 · Regulation
№103-2 · 5 Jul 2019 · Regulation
In 2013, Romania passed an extremely narrow legalisation of medical cannabis treatment, allowing the use of derivatives of cannabis up to 0.2% THC in medical treatment.
The 2013 law also theoretically permitted the cultivation, manufacture, import and export of cannabis under licence, though no such licences have been granted for medical cannabis.
In 2019, a draft law expanding medical cannabis access and further regulating its cultivation and manufacture in Romania was adopted by parliament, but was ultimately rejected by parliamentary vote.
The current situation is that further regulatory frameworks need to be established before either medical cannabis treatment or production is a practical possibility in Romania.
